The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression

Bibliography

• du Souich P, McLean AJ, Lalka D, Pulmonary disease and drug kinetics. Clin Pharmacokinet 1978;7:257-66
   Google Scholar
• Piafsky KM, Sitar DS, Rangno RE, Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther 1977;21:310-16
   PubMed Web of Science ®Google Scholar
• Powell JR, Vozeh S, Hopewell P, Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia. Am Rev Respir Dis 1978;118:229-38
   PubMed Web of Science ®Google Scholar
• Vozeh S, Powell JR, Riegelman S, Changes in theophylline clearance during acute illness. JAMA 1978;240:1882-4
   PubMed Web of Science ®Google Scholar
• Dumais G, Iovu M, du Souich P. Inflammatory reactions and drug response. Expert Rev Clin Pharmacol 2008;1:627-47
   PubMedGoogle Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39
   PubMed Web of Science ®Google Scholar
• Engel G, Hofmann U, Heidemann H, Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin Pharmacol Ther 1996;59:613-23
   PubMed Web of Science ®Google Scholar
• Cumming JF. The effect of arterial oxygen tension on antipyrine half-time in plasma. Clin Pharmacol Ther 1976;19:498-71
   PubMedGoogle Scholar
• Laybourn C, Tonnesen P, Loft S, Pulmonary disease and antipyrine clearance. Clin Pharmacol Ther 1986;40:415-19
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Kaminsky LS. Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem Pharmacol 1995;50:205-11
   PubMed Web of Science ®Google Scholar
• Mitenko PA, Ogilvie RI. Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther 1973;14:509-13
   PubMed Web of Science ®Google Scholar
• Richer M, Lam YW. Hypoxia, arterial pH and theophylline disposition. Clin Pharmacokinet 1993;25:283-99
   PubMed Web of Science ®Google Scholar
• Vicuna N, McNay JL, Ludden TM, Impaired theophylline clearance in patients with cor pulmonale. Br J Clin Pharmacol 1979;7:33-7
   PubMed Web of Science ®Google Scholar
• Cusack BJ, Crowley JJ, Mercer GD, Theophylline clearance in patients with severe chronic obstructive pulmonary disease receiving supplemental oxygen and the effect of acute hypoxemia. Am Rev Respir Dis 1986;133:1110-14
   PubMed Web of Science ®Google Scholar
• du Souich P, Hoen B, Saunier C, Theophylline disposition in patients with COLD with and without hypoxemia. Chest 1989;95:1028-32
   PubMed Web of Science ®Google Scholar
• Sotaniemi E, Arvela P, Huhti E. Increased clearance of tolbutamide from the blood of asthmatic patients. Ann Allergy 1971;29:139-41
   PubMedGoogle Scholar
• Lasker JM, Wester MR, Aramsombatdee E, Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Arch Biochem Biophys 1998;353:16-28
   PubMed Web of Science ®Google Scholar
• du Souich P, Erill S. Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. Eur J Clin Pharmacol 1978;14:21-7
   PubMed Web of Science ®Google Scholar
• du Souich P, Amyot R, Julien M, Influence of chronic obstructive lung disease on the disposition of an acidic drug (sulfamethazine). Arch Intern Med 1983;143:233-6
   PubMed Web of Science ®Google Scholar
• Jurgens G, Christensen HR, Brosen K, Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. Clin Pharmacol Ther 2002;71:214-20
   PubMed Web of Science ®Google Scholar
• Kamimori GH, Eddington ND, Hoyt RW, Effects of altitude (4300 m) on the pharmacokinetics of caffeine and cardio-green in humans. Eur J Clin Pharmacol 1995;48:167-70
   PubMed Web of Science ®Google Scholar
• Fradette C, du Souich P. Effect of hypoxia on cytochrome P450 activity and expression. Curr Drug Metab 2004;5:257-71
   PubMed Web of Science ®Google Scholar
• Letarte L, du Souich P. Influence of hypercapnia and/or hypoxemia and metabolic acidosis on theophylline kinetics in the conscious rabbit. Am Rev Respir Dis 1984;129:762-6
   PubMed Web of Science ®Google Scholar
• Saunier C, du Souich P, Hartemann D, Theophylline disposition during acute and chronic hypoxia in the conscious dog. Res Commun Chem Pathol Pharmacol 1987;57:291-9
   PubMedGoogle Scholar
• Wang JS, Backman JT, Taavitsainen P, Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans. Drug Metab Dispos 2000;28:959-65
   PubMed Web of Science ®Google Scholar
• Marleau S, Ong H, Gariepy L, Lidocaine and indocyanine green kinetics: effect of hypoxemia and/or hypercapnia. J Pharmacol Exp Ther 1987;242:338-43
   PubMed Web of Science ®Google Scholar
• Sutton D, Butler AM, Nadin L, Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. J Pharmacol Exp Ther 1997;282:294-300
   PubMed Web of Science ®Google Scholar
• du Souich P, Saunier C, Hartemann D, Effect of acute and chronic moderate hypoxia on the kinetics of lidocaine and its metabolites and on regional blood flow. Pulm Pharmacol 1992;5:9-16
   PubMedGoogle Scholar
• du Souich P, Hartemann D, Saunier C. Effect of acute and chronic moderate hypoxia on diltiazem kinetics and metabolism in the dog. Pharmacology 1993;47:378-85
   PubMed Web of Science ®Google Scholar
• du Souich P, Varin F, Courteau H. Effect of hypercapnia and/or hypoxemia and metabolic acidosis on kinetics and concentrations of phenytoin in the cerebrospinal fluid of conscious rabbits. Neuropharmacology 1986;25:857-62
   PubMed Web of Science ®Google Scholar
• Giancarlo GM, Venkatakrishnan K, Granda BW, Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur J Clin Pharmacol 2001;57:31-6
   PubMed Web of Science ®Google Scholar
• Gavalakis J, du Souich P, Sharkawi M. Acute moderate hypoxia reduces ethanol elimination in the conscious rabbit. Toxicology 1999;137:109-16
   PubMed Web of Science ®Google Scholar
• Fradette C, Batonga J, Teng S, Animal models of acute moderate hypoxia are associated with a down-regulation of CYP1A1, 1A2, 2B4, 2C5, and 2C16 and up-regulation of CYP3A6 and P-glycoprotein in liver. Drug Metab Dispos 2007;35:765-71
   PubMed Web of Science ®Google Scholar
• Dopp JM, Moran JJ, Abel NJ, Influence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent model. Pharmacotherapy 2009;29:365-72
   PubMed Web of Science ®Google Scholar
• Fradette C, du Souich P. Hypoxia-inducible factor-1 and activator protein-1 modulate the upregulation of CYP3A6 induced by hypoxia. Br J Pharmacol 2003;140:1146-54
   PubMed Web of Science ®Google Scholar
• Legendre C, Hori T, Loyer P, Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression. Eur J Cancer 2009;45:2882-92
   PubMed Web of Science ®Google Scholar
• Loot AE, Fleming I. Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential (TRP) C6 channels. J Cardiovasc Pharmacol 2011;57:140-7
   PubMed Web of Science ®Google Scholar
• Pokreisz P, Fleming I, Kiss L, Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 2006;47:762-70
   PubMed Web of Science ®Google Scholar
• Michaelis UR, Fisslthaler B, Barbosa-Sicard E, Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci 2005;118:5489-98
   PubMed Web of Science ®Google Scholar
• Yang B, Graham L, Dikalov S, Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 2001;60:310-20
   PubMed Web of Science ®Google Scholar
• Chiche J, Brahimi-Horn MC, Pouyssegur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 2010;14:771-94
   PubMed Web of Science ®Google Scholar
• Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 2007;53:233-56
   PubMed Web of Science ®Google Scholar
• Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006;281:9030-7
   PubMed Web of Science ®Google Scholar
• Shayeghi M, Latunde-Dada GO, Oakhill JS, Identification of an intestinal heme transporter. Cell 2005;122:789-801
   PubMed Web of Science ®Google Scholar
• Lis A, Paradkar PN, Singleton S, Hypoxia induces changes in expression of isoforms of the divalent metal transporter (DMT1) in rat pheochromocytoma (PC12) cells. Biochem Pharmacol 2005;69:1647-55
   PubMed Web of Science ®Google Scholar
• Scafidi S, Douglas RM, Farahani R, Prostaglandin transporter expression in mouse brain during development and in response to hypoxia. Neuroscience 2007;146:1150-7
   PubMed Web of Science ®Google Scholar
• Hsu L, Rockenstein E, Mallory M, Altered expression of glutamate transporters under hypoxic conditions in vitro. J Neurosci Res 2001;64:193-202
   PubMed Web of Science ®Google Scholar
• Carpenter TC, Schomberg S, Nichols C, Hypoxia reversibly inhibits epithelial sodium transport but does not inhibit lung ENaC or Na-K-ATPase expression. Am J Physiol Lung Cell Mol Physiol 2003;284:L77-83
   PubMed Web of Science ®Google Scholar
• MacLean MR, Deuchar GA, Hicks MN, Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 2004;109:2150-5
   PubMed Web of Science ®Google Scholar
• Comerford KM, Wallace TJ, Karhausen J, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002;62:3387-94
   PubMed Web of Science ®Google Scholar
• Wartenberg M, Ling FC, Muschen M, Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 2003;17:503-5
   PubMed Web of Science ®Google Scholar
• Ding Z, Yang L, Xie X, Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells. J Cancer Res Clin Oncol 2010;136:1697-707
   PubMed Web of Science ®Google Scholar
• Liu L, Ning X, Sun L, Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 2008;99:121-8
   PubMed Web of Science ®Google Scholar
• Thews O, Gassner B, Kelleher DK, Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 2006;8:143-52
   PubMed Web of Science ®Google Scholar
• Lotz C, Kelleher DK, Gassner B, Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells. Oncol Rep 2007;17:239-44
   PubMed Web of Science ®Google Scholar
• Fouassier L, Beaussier M, Schiffer E, Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol 2007;293:G25-35
   PubMed Web of Science ®Google Scholar
• Rytting E, Audus KL. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells. J Pharm Pharmacol 2007;59:1095-102
   PubMed Web of Science ®Google Scholar
• Liu YV, Semenza GL. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007;6:656-9
   PubMed Web of Science ®Google Scholar
• Zhang N, Walker MK. Crosstalk between the aryl hydrocarbon receptor and hypoxia on the constitutive expression of cytochrome P4501A1 mRNA. Cardiovasc Toxicol 2007;7:282-90
   PubMed Web of Science ®Google Scholar
• Allen JW, Johnson RS, Bhatia SN. Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha. Toxicol Lett 2005;155:151-9
   PubMed Web of Science ®Google Scholar
• Oliver KM, Garvey JF, Ng CT, Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal 2009;11:2057-64
   PubMed Web of Science ®Google Scholar
• Tian Y, Ke S, Denison MS, Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 1999;274:510-15
   PubMed Web of Science ®Google Scholar
• Schoemaker MH, Ros JE, Homan M, Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis. J Hepatol 2002;36:742-50
   PubMed Web of Science ®Google Scholar
• Chan WK, Yao G, Gu YZ, Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J Biol Chem 1999;274:12115-23
   PubMed Web of Science ®Google Scholar
• Barouki R, Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 2001;61:511-16
   PubMed Web of Science ®Google Scholar
• Takada Y, Mukhopadhyay A, Kundu GC, Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 2003;278:24233-41
   PubMed Web of Science ®Google Scholar
• Chung I, Bresnick E. Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch Biochem Biophys 1997;338:220-6
   PubMed Web of Science ®Google Scholar
• Abdel-Razzak Z, Corcos L, Fautrel A, Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol 1994;46:1100-10
   PubMed Web of Science ®Google Scholar
• Lim YP, Huang JD. Interplay of pregnane X receptor with other nuclear receptors on gene regulation. Drug Metab Pharmacokinet 2008;23:14-21
   PubMed Web of Science ®Google Scholar
• Huss JM, Levy FH, Kelly DP. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 2001;276:27605-12
   PubMed Web of Science ®Google Scholar
• Jover R, Moya M, Gomez-Lechon MJ. Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alpha. Curr Drug Metab 2009;10:508-19
   PubMed Web of Science ®Google Scholar
• Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J Clin Pharmacol 2007;47:566-78
   PubMed Web of Science ®Google Scholar
• Root B, Abrassart J, Myers DA, Expression and distribution of glucocorticoid receptors in the ovine fetal adrenal cortex: effect of long-term hypoxia. Reprod Sci 2008;15:517-28
   PubMed Web of Science ®Google Scholar
• Leonard MO, Godson C, Brady HR, Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol 2005;174:2250-7
   PubMed Web of Science ®Google Scholar
• Pirkmajer S, Filipovic D, Mars T, HIF-1alpha response to hypoxia is functionally separated from the glucocorticoid stress response in the in vitro regenerating human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2010;299:R1693-700
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao JJ, Lv YY, Hypoxia down-regulates glucocorticoid receptor alpha and attenuates the anti-inflammatory actions of dexamethasone in human alveolar epithelial A549 cells. Life Sci 2009;85:107-12
   PubMed Web of Science ®Google Scholar
• Pascussi JM, Gerbal-Chaloin S, Drocourt L, Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 2004;34:633-64
   PubMed Web of Science ®Google Scholar
• Zhang Y, Edwards PA. FXR signaling in metabolic disease. FEBS Lett 2008;582:10-18
   PubMed Web of Science ®Google Scholar
• Fujino T, Murakami K, Ozawa I, Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. FEBS J 2009;276:1319-32
   PubMed Web of Science ®Google Scholar
• Piguet AC, Stroka D, Zimmermann A, Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clin Sci (Lond). 2009;118:401-10
   PubMed Web of Science ®Google Scholar
• Itoigawa Y, Kishimoto KN, Okuno H, Hypoxia induces adipogenic differentitation of myoblastic cell lines. Biochem Biophys Res Commun 2010;399:721-6
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Y, Schmelzer K, The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc Natl Acad Sci USA 2005;102:16747-52
   PubMed Web of Science ®Google Scholar
• Li R, Fan W, Tian G, The sequence and de novo assembly of the giant panda genome. Nature 2010;463:311-17
   PubMed Web of Science ®Google Scholar
• Fogli S, Pellegrini S, Adinolfi B, Rosiglitazone reverses salbutamol-induced beta(2)-adrenoceptor tolerance in airway smooth muscle. Br J Pharmacol 2011;162:378-91
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee JY, Jung HS, The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes. Int J Tuberc Lung Dis 2010;14:362-7
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez CP, Jover R, Donato MT, Transcriptional regulation and expression of CYP3A4 in hepatocytes. Curr Drug Metab 2007;8:185-94
   PubMed Web of Science ®Google Scholar
• Marden NY, Fiala-Beer E, Xiang SH, Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 2003;373:669-80
   PubMed Web of Science ®Google Scholar
• Iber H, Li-Masters T, Chen Q, Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation. J Pharmacol Exp Ther 2001;297:174-80
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez CP, Gomez-Lechon MJ, Castell JV, Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein). Mol Pharmacol 2005;67:2088-101
   PubMed Web of Science ®Google Scholar
• Seifeddine R, Fulchignoni-Lataud MC, Massaad-Massade L. Down-regulation of C/EBPalpha in breast cancer cells by hypoxia-estrogen combination is mainly due to hypoxia. Anticancer Res 2009;29:1227-31
   PubMed Web of Science ®Google Scholar
• Park YK, Park H. Prevention of CCAAT/enhancer-binding protein beta DNA binding by hypoxia during adipogenesis. J Biol Chem 2010;285:3289-99
   PubMed Web of Science ®Google Scholar
• Yang L, Jiang Y, Wu SF, CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis 2008;29:291-8
   PubMed Web of Science ®Google Scholar
• Sow FB, Alvarez GR, Gross RP, Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J Leukoc Biol 2009;86:1247-58
   PubMed Web of Science ®Google Scholar
• Fradette C, Bleau AM, Pichette V, Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators. Br J Pharmacol 2002;137:881-91
   PubMed Web of Science ®Google Scholar
• Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 2009;114:2015-19
   PubMed Web of Science ®Google Scholar
• Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16:1151-62
   PubMed Web of Science ®Google Scholar
• Seta KA, Millhorn DE. Functional genomics approach to hypoxia signaling. J Appl Physiol 2004;96:765-73
   PubMed Web of Science ®Google Scholar
• Gorlach A, Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J 2008;412:e17-19
   PubMedGoogle Scholar
• Liu M, Li D, Aneja R, PO(2)-dependent differential regulation of multidrug resistance 1 gene expression by the c-Jun NH2-terminal kinase pathway. J Biol Chem 2007;282:17581-6
   PubMed Web of Science ®Google Scholar
• Thews O, Dillenburg W, Fellner M, Activation of P-glycoprotein (Pgp)-mediated drug efflux by extracellular acidosis: in vivo imaging with 68Ga-labelled PET tracer. Eur J Nucl Med Mol Imaging 2010;37:1935-42
   PubMed Web of Science ®Google Scholar
• Razeghi P, Baskin KK, Sharma S, Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem Biophys Res Commun 2006;342:361-4
   PubMed Web of Science ®Google Scholar
• Krajewski J, Batmunkh C, Jelkmann W, Interleukin-1beta inhibits the hypoxic inducibility of the erythropoietin enhancer by suppressing hepatocyte nuclear factor-4alpha. Cell Mol Life Sci 2007;64:989-98
   PubMed Web of Science ®Google Scholar
• Osna NA, Clemens DL, Donohue TM Jr. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. Biochem Pharmacol 2003;66:697-710
   PubMed Web of Science ®Google Scholar
• Lefebvre B, Benomar Y, Guedin A, Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. J Clin Invest 2010;120:1454-68
   PubMed Web of Science ®Google Scholar
• Ma Q, Baldwin KT. 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AhR. J Biol Chem 2000;275:8432-8
   PubMed Web of Science ®Google Scholar
• Choi HS, Seol W, Moore DD. A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily. J Steroid Biochem Mol Biol 1996;56:23-30
   PubMed Web of Science ®Google Scholar
• Masuyama H, Inoshita H, Hiramatsu Y, Ligands have various potential effects on the degradation of pregnane X receptor by proteasome. Endocrinology 2002;143:55-61
   PubMed Web of Science ®Google Scholar
• Masuyama H, MacDonald PN. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR. J Cell Biochem 1998;71:429-40
   PubMed Web of Science ®Google Scholar
• Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 2001;276:42714-21
   PubMed Web of Science ®Google Scholar
• Choi H, Chun YS, Kim SW, Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Mol Pharmacol 2006;70:1664-71
   PubMed Web of Science ®Google Scholar
• Cribb AE, Peyrou M, Muruganandan S, The endoplasmic reticulum in xenobiotic toxicity. Drug Metab Rev 2005;37:405-42
   PubMed Web of Science ®Google Scholar
• Meir O, Dvash E, Werman A, C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models. PLoS One 2010;5:e9516
   PubMed Web of Science ®Google Scholar
• Correia MA, Sadeghi S, Mundo-Paredes E. Cytochrome P450 ubiquitination: branding for the proteolytic slaughter? Annu Rev Pharmacol Toxicol 2005;45:439-64
   PubMed Web of Science ®Google Scholar
• Roberts BJ. Evidence of proteasome-mediated cytochrome P-450 degradation. J Biol Chem 1997;272:9771-8
   PubMed Web of Science ®Google Scholar
• Xie Y, Burcu M, Linn DE, Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression. Mol Pharmacol 2010;78:310-18
   PubMed Web of Science ®Google Scholar
• Yang ZZ, Zou AP. Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells. Am J Physiol Renal Physiol 2001;281:F900-8
   PubMed Web of Science ®Google Scholar
• Chepelev NL, Willmore WG. Regulation of iron pathways in response to hypoxia. Free Radic Biol Med 2011;50:645-66
   PubMed Web of Science ®Google Scholar
• Reed JR, Cawley GF, Backes WL. Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes. Drug Metab Lett 2011;5:6-16
   PubMedGoogle Scholar
• Zhou SF, Wang B, Yang LP, Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2. Drug Metab Rev 2010;42:268-354
   PubMed Web of Science ®Google Scholar
• Kurdi J, Maurice H, El-Kadi AO, Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. Br J Pharmacol 1999;128:365-73
   PubMed Web of Science ®Google Scholar
• Lee CA, Neul D, Clouser-Roche A, Identification of novel substrates for human cytochrome P450 2J2. Drug Metab Dispos 2010;38:347-56
   PubMed Web of Science ®Google Scholar
• Yaghi A, Bradbury JA, Zeldin DC, Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia. Am J Physiol Lung Cell Mol Physiol 2003;285:L1099-105
   PubMed Web of Science ®Google Scholar
• Zordoky BN, El-Kadi AO. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 2010;125:446-63
   PubMed Web of Science ®Google Scholar
• Ross DD, Nakanishi T. Impact of breast cancer resistance protein on cancer treatment outcomes. Methods Mol Biol 2010;596:251-90
   PubMedGoogle Scholar
• Norris MD, Bordow SB, Marshall GM, Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med 1996;334:231-8
   PubMed Web of Science ®Google Scholar
• Hoffmann AC, Wild P, Leicht C, MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. Neoplasia 2010;12:628-36
   PubMed Web of Science ®Google Scholar
• Langer R, Ott K, Feith M, High pretherapeutic thymidylate synthetase and MRP-1 protein levels are associated with nonresponse to neoadjuvant chemotherapy in oesophageal adenocarcinoma patients. J Surg Oncol 2010;102:503-8
   PubMed Web of Science ®Google Scholar
• van der Holt B, Lowenberg B, Burnett AK, The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. Blood 2005;106:2646-54
   PubMed Web of Science ®Google Scholar
• Cripe LD, Uno H, Paietta EM, Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood 2010;116:4077-85
   PubMed Web of Science ®Google Scholar
• Mazure NM, Brahimi-Horn MC, Berta MA, HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004;68:971-80
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16:63-70
   PubMed Web of Science ®Google Scholar
• Loke YK, Kwok CS, Singh S, Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD. Eur Respir J 2010;35:1003-21
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Celli B, Senn S, A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-54
   PubMed Web of Science ®Google Scholar